×
Tel: +46 (0)708 55 11 85. E-mail: stefan.olsson@enzymatica.com. Therese Filmersson. CFO, Enzymatica AB. Tel: +46 (0)708-40 72 24.
Investors ; April 9, 2024. Enzymatica publishes annual report for 2023 ; February 16, 2024. Year-end report 2023: Scientific and regulatory progress generating ...
The Investor Relations website contains information about Inozyme Pharma, Inc.'s business for stockholders, potential investors, and financial analysts.
Investors · Overview · News & Events · Overview · Press Releases · IR Calendar · Email Alerts · Company Info · Overview · Management Team · Presentations ...
Missing: enzy | Show results with:enzy
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
Investor Relations · Advanced Enzyme Technologies Limited – A Rising Global Star · Revenue from Operations · EBIDTA & EBIDTA Margin (%) · PAT & PAT Margin (%).
Enzychem Lifesciences Announces Poster Presentation of EC-18 Abstract at the ASCO 2022 Annual Meeting. ENGLEWOOD CLIFFS, N.J.–(BUSINESS WIRE)–Enzychem ...
People also ask
Investor Relations. Q1 2024 Earnings Conference ... enzymes for research and diagnostic use and ... Alphazyme is a manufacturer of molecular biology enzymes, ...
Other Reports · 2022 Form SD · 2021 Form SD · 2020 Form SD · 2019 Form SD · 2018 Form SD · 2017 Form SD · 2016 Form SD · 2015 Form SD ...
Kerry Group is the leading taste and nutrition ingredient company. Explore investor insights, shareholder information, and the latest stock details.